Concept information
Terme préférentiel
Pyridinolcarbamate
Type
-
mesh:Descriptor
Définition
- A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
Concept générique
Synonyme(s)
- 1882-26-4 (Pyridinolcarbamate)
- 2,6-Pyridinedimethanol, bis(methylcarbamate) (ester)
- 2,6-Pyridinedimethanol-bis-(N-methylcarbamate)
- 81R511UV73
- Pyricarbate
Qualificatif(s) autorisé(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Action(s) pharmacologique(s)
Traductions
-
français
-
1882-26-4 (Pyridinolcarbamate)
-
2,6-Pyridinedimethanol, bis(methylcarbamate) (ester)
-
81R511UV73
-
Pyridinol carbamate
URI
http://data.loterre.fr/ark:/67375/JVR-R8CV6833-Z
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}